Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Stakeholders

2. Research & Forecasting

• 2.1. Research Methodology
  • 2.1.1. Research Instruments
    • 2.1.1.1. Secondary Instrument
    • 2.1.1.2. Primary Instrument
  • 2.1.2. Research Approaches
    • 2.1.2.1. Bottom-up Approach
    • 2.1.2.2. Top-down Approach
  • 2.1.3. Research Reliability & Validity
  • 2.1.4. Research Assumptions
  • 2.1.5. Vendor Inclusion Criteria
• 2.2. Forecasting Methodology
  • 2.2.1. Methodology for Market Estimation & Forecasting
  • 2.2.2. Significance and Importance of the Market Estimation & Forecasting

3. Executive Summary

4. Premium Insight

• 4.1. Market Connectivity
• 4.2. Market Data Feed
• 4.3. Market Vendor Ranking Analysis
• 4.4. Market Dynamics
  • 4.4.1. Drivers
  • 4.4.2. Restraints
  • 4.4.3. Opportunities
  • 4.4.4. Challenges
• 4.5. Porter’s Five Forces Analysis
  • 4.5.1. Threat of New Entrants
  • 4.5.2. Threat of Substitutes
  • 4.5.3. Bargaining Power of Customers
  • 4.5.4. Bargaining Power of Suppliers
  • 4.5.5. Industry Rivalry

5. Global Digital Therapeutics Market, by Indication

• 5.1. Introduction
• 5.2. Cardiovascular Diseases
• 5.3. Central Nervous System (CNS) Disorders
• 5.4. Chronic Respiratory Diseases (CRD)
• 5.5. Diabetes
• 5.6. Medication Adherence
• 5.7. Musculoskeletal Disorders
• 5.8. Obesity
• 5.9. Prediabetes
• 5.10. Smoking Cessation

6. Global Digital Therapeutics Market, by Sales Channel

• 6.1. Introduction
• 6.2. B2B
  • 6.2.1. Employers
  • 6.2.2. Payers
  • 6.2.3. Pharmaceutical Companies
  • 6.2.4. Providers
• 6.3. B2C
  • 6.3.1. Caregivers
  • 6.3.2. Patients

7. Global Digital Therapeutics Market, by Geography

• 7.1. Introduction
• 7.2. Americas Digital Therapeutics Market
  • 7.2.1. Americas Digital Therapeutics Market, by Country
    • 7.2.1.1. United States
    • 7.2.1.2. Brazil
    • 7.2.1.3. Canada
    • 7.2.1.4. Mexico
    • 7.2.1.5. Argentina
  • 7.2.2. Americas Digital Therapeutics Market, by Indication
  • 7.2.3. Americas Digital Therapeutics Market, by Sales Channel
• 7.3. Europe, Middle East & Africa Digital Therapeutics Market
  • 7.3.1. Europe, Middle East & Africa Digital Therapeutics Market, by Country
    • 7.3.1.1. United Kingdom
    • 7.3.1.2. Germany
    • 7.3.1.3. France
    • 7.3.1.4. Saudi Arabia
    • 7.3.1.5. United Arab Emirates
    • 7.3.1.6. Italy
    • 7.3.1.7. Russia
  • 7.3.2. Europe, Middle East & Africa Digital Therapeutics Market, by Indication
  • 7.3.3. Europe, Middle East & Africa Digital Therapeutics Market, by Sales Channel
• 7.4. Asia-Pacific Digital Therapeutics Market
  • 7.4.1. Asia-Pacific Digital Therapeutics Market, by Country
    • 7.4.1.1. China
    • 7.4.1.2. Japan
    • 7.4.1.3. India
    • 7.4.1.4. Australia
  • 7.4.2. Asia-Pacific Digital Therapeutics Market, by Indication
  • 7.4.3. Asia-Pacific Digital Therapeutics Market, by Sales Channel

8. Competitive Strategic Window

• 8.1. Introduction
  • 8.1.1. Leverage Zone
  • 8.1.2. Vantage Zone
  • 8.1.3. Speculative Zone
  • 8.1.4. Bottleneck Zone

9. FPNV Positioning Matrix

• 9.1. Introduction
• 9.2. Scores
  • 9.2.1. Forefront
  • 9.2.2. Pathfinders
  • 9.2.3. Niche
  • 9.2.4. Vital
• 9.3. Business Strategy
• 9.4. Product Satisfaction

10. Competitive News Feed Analysis

11. Company Usability Profiles

• 11.1. 2morrow Inc.
• 11.2. Canary Health Inc.
• 11.3. Ginger.Io, Inc.
• 11.4. Livongo Health
• 11.5. Mango Health Inc.
• 11.6. Noom Inc.
• 11.7. Omada Health, Inc.
• 11.8. Propeller Health
• 11.9. Proteus Digital Health, Inc.
• 11.10. Welldoc, Inc.

12. Appendix

• 12.1. Top Reports
• 12.2. Author Details

LIST OF TABLES (31 TABLES)

TABLE 1. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2016 - 2024 (USD MILLION)

TABLE 2. GLOBAL DIGITAL THERAPEUTICS MARKET RANKING, BY VENDORS, 2017

TABLE 3. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2016 - 2024 (USD MILLION)

TABLE 4. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 5. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM (CNS) DISORDERS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 6. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHRONIC RESPIRATORY DISEASES (CRD), BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 7. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 8. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MEDICATION ADHERENCE, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 9. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 10. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 11. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PREDIABETES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 12. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SMOKING CESSATION, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 13. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL, 2016 - 2024 (USD MILLION)

TABLE 14. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 15. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 16. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 17. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, 2016 - 2024 (USD MILLION)

TABLE 18. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2016 - 2024 (USD MILLION)

TABLE 19. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL, 2016 - 2024 (USD MILLION)

TABLE 20. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, 2016 - 2024 (USD MILLION)

TABLE 21. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2016 - 2024 (USD MILLION)

TABLE 22. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL, 2016 - 2024 (USD MILLION)

TABLE 23. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, 2016 - 2024 (USD MILLION)

TABLE 24. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2016 - 2024 (USD MILLION)

TABLE 25. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL, 2016 - 2024 (USD MILLION)

TABLE 26. 360IRESEARCH SCORES FOR FOREFRONT IN DIGITAL THERAPEUTICS MARKET

TABLE 27. 360IRESEARCH SCORES FOR PATHFINDERS IN DIGITAL THERAPEUTICS MARKET

TABLE 28. 360IRESEARCH SCORES FOR NICHE IN DIGITAL THERAPEUTICS MARKET

TABLE 29. 360IRESEARCH SCORES FOR VITAL IN DIGITAL THERAPEUTICS MARKET

TABLE 30. 360IRESEARCH FPNV POSITIONING MATRIX BUSINESS STRATEGY FOR DIGITAL THERAPEUTICS MARKET

TABLE 31. 360IRESEARCH FPNV POSITIONING MATRIX PRODUCT SATISFACTION FOR DIGITAL THERAPEUTICS MARKET

LIST OF FIGURES (29 TABLES)

FIGURE 1. GLOBAL DIGITAL THERAPEUTICS MARKET: YEARS CONSIDERED FOR THE STUDY

FIGURE 2. GLOBAL DIGITAL THERAPEUTICS MARKET: KEY RESEARCH METHODOLOGY

FIGURE 3. GLOBAL DIGITAL THERAPEUTICS MARKET: KEY RESEARCH INSTRUMENTS

FIGURE 4. GLOBAL DIGITAL THERAPEUTICS MARKET: KEY SECONDARY INSTRUMENT SOURCES

FIGURE 5. GLOBAL DIGITAL THERAPEUTICS MARKET: KEY POTENTIAL RESPONDENTS

FIGURE 6. GLOBAL DIGITAL THERAPEUTICS MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT

FIGURE 7. GLOBAL DIGITAL THERAPEUTICS MARKET: KEY RESEARCH APPROACHES

FIGURE 8. GLOBAL DIGITAL THERAPEUTICS MARKET: KEY DATA TRIANGULATION

FIGURE 9. GLOBAL DIGITAL THERAPEUTICS MARKET: KEY RESEARCH ASSUMPTIONS

FIGURE 10. DIGITAL THERAPEUTICS MARKET: KEY MARKET CONNECTIVITY

FIGURE 11. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2016 - 2024 (USD MILLION)

FIGURE 12. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2017 VS 2024 (USD MILLION)

FIGURE 13. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 14. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM (CNS) DISORDERS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 15. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHRONIC RESPIRATORY DISEASES (CRD), BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 16. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 17. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MEDICATION ADHERENCE, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 18. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 19. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 20. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PREDIABETES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 21. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SMOKING CESSATION, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 22. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL, 2017 VS 2024 (USD MILLION)

FIGURE 23. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 24. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 25. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2017 (USD MILLION)

FIGURE 26. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIGITAL THERAPEUTICS MARKET, BY INDICATION, 2024

FIGURE 27. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2024

FIGURE 28. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIGITAL THERAPEUTICS MARKET, BY GEOGRAPHY, 2024

FIGURE 29. 360IRESEARCH FPNV POSITIONING MATRIX FOR DIGITAL THERAPEUTICS MARKET

The global digital therapeutics market is expected to grow from USD 2,462.27 million 2017 to USD 7,635.55 million by the end of 2024 at a Compound Annual Growth Rate (CAGR) of 17.55%.

On the basis of indication, the global digital therapeutics market is studied across Cardiovascular Diseases, Central Nervous System (CNS) Disorders, Chronic Respiratory Diseases (CRD), Diabetes, Medication Adherence, Musculoskeletal Disorders, Obesity, Prediabetes, and Smoking Cessation.

On the basis of sales channel, the global digital therapeutics market is studied across B2B and B2C.

On the basis of geography, the global digital therapeutics market is studied across Americas, (United States, Brazil, Canada, Mexico, and Argentina) Europe, Middle East & Africa, (United Kingdom, Germany, France, Saudi Arabia, United Arab Emirates, Italy, and Russia) and Asia-Pacific (China, Japan, India, and Australia).

“2morrow Inc.: The potential growing player for the global digital therapeutics market”

The key players profiled in the global digital therapeutics market are 2morrow Inc., Canary Health Inc., Ginger.Io, Inc., Livongo Health, Mango Health Inc., Noom Inc., Omada Health, Inc., Propeller Health, Proteus Digital Health, Inc., and Welldoc, Inc..

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the global digital therapeutics market.
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the global digital therapeutics market.
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the global digital therapeutics market.
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the global digital therapeutics market.
5. Competitive Assessment & Intelligence: Provides exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global digital therapeutics market.